Catalyst Wire Dossier Catalyst Wire Dossier

Fimasartan + statin

fimasartan and statin · Boryung Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fimasartan + statin, covering 2024-12-27 to 2024-12-27. Get the full timeline:

Most recent: Clinical Trial Update: A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia

See pricing